Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
91,313
-
Share change
-
+29,401
-
Total reported value
-
$1,278,548
-
Price per share
-
$14.00
-
Number of holders
-
18
-
Value change
-
+$420,748
-
Number of buys
-
7
-
Number of sells
-
5
Institutional Holders of MiNK Therapeutics, Inc. - COM NEW (INKT) as of Q3 2025
As of 30 Sep 2025,
MiNK Therapeutics, Inc. - COM NEW (INKT) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
91,313 shares.
The largest 10 holders included
VANGUARD GROUP INC, Longbow Finance SA, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., UBS Group AG, Tower Research Capital LLC (TRC), BANK OF AMERICA CORP /DE/, Covestor Ltd, and OSAIC HOLDINGS, INC..
This page lists
18
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.